Skip to main content
Pulmatrix, Inc. logo

Pulmatrix, Inc. — Investor Relations & Filings

Ticker · PULM ISIN · US74584P3010 LEI · 5299002RHCRZ9ST3GN42 US Manufacturing
Filings indexed 616 across all filing types
Latest filing 2017-01-13 Regulatory Filings
Country US United States of America
Listing US PULM

About Pulmatrix, Inc.

https://www.pulmatrix.com/

Pulmatrix, Inc. is a clinical-stage biopharmaceutical company that develops novel inhaled therapeutic products for respiratory and other diseases. The company's core is its proprietary iSPERSE™ technology, an engineered dry powder platform designed for efficient drug delivery directly to the lungs. This technology aims to improve therapeutic outcomes for patients with serious pulmonary conditions. The company's development pipeline has included candidates for diseases such as Chronic Obstructive Pulmonary Disease (COPD). In late 2024, Pulmatrix announced a proposed merger with Cullgen Inc., a company focused on targeted protein degradation, to form a combined entity with a diversified clinical pipeline.

Recent filings

Filing Released Lang Actions
FORM 8-K
Regulatory Filings
2017-01-13 English
FORM 8-K
Regulatory Filings
2016-12-23 English
10-Q
Interim / Quarterly Report Q3 2016
2016-11-04 English
8-K
Regulatory Filings
2016-11-04 English
FORM 8-K
Regulatory Filings
2016-10-25 English
Regulatory Filings 2016
Regulatory Filings
2016-10-21 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.